Ted W. Love, MD
Chair of Board of Directors, Biotechnology Innovation Organization
Dr. Love joined our Board in February 2024. He is the Chair of the board of directors of the Biotechnology Innovation Organization. From 2014 to 2022, Dr. Love was the President and Chief Executive Officer of Global Blood Therapeutics, Inc., where he led the company from a pre-clinical startup through its growth to a global commercial company with a pipeline of innovative therapies focused on sickle cell disease. Previously, he was Executive Vice President, Research and Development and Technical Operations at Onyx Pharmaceuticals, Inc. He also served as President, Chief Executive Officer and Chairman of Nuvelo, Inc., and Senior Vice President, Development at Theravance Biopharma, Inc. He began his biotech career at Genentech, Inc., where he held several senior management positions in clinical science and product development, and ultimately as chair of Genentech’s Product Development Committee. Prior to Genentech, Dr. Love was a member of the Department of Cardiology at the Massachusetts General Hospital. Known for championing access to care, Dr. Love received the William E. Proudford Sickle Cell Fund 2023 Distinguished Service Award. He also earned the Spirit of the Heart Health Equity Champion Award from the Association of Black Cardiologists in 2023. Dr. Love currently serves on the board of directors of Royalty Pharma plc and Structure Therapeutics Inc. He previously served on the board of directors of Seagen Inc., from 2020 to 2023; Global Blood Therapeutics from 2013 to 2022; Portola Pharmaceuticals, Inc., from 2019 to 2020; and Amicus Therapeutics, Inc., from 2012 to 2020.
-
Daniel O’Day
Chairman and Chief Executive Officer
-
Jacqueline K. Barton, PhD
Professor, California Institute of Technology
-
Jeffrey A. Bluestone, PhD
President and Chief Executive Officer, Sonoma Biotherapeutics; A.W. and Mary Margaret Clausen Distinguished Professor in the Diabetes Center at University of California San Francisco
-
Sandra J. Horning, MD
Retired, Chief Medical Officer, Roche, Inc.; Emerita Professor, Stanford University
-
Kelly A. Kramer
Retired, Executive Vice President and Chief Financial Officer, Cisco Systems, Inc.
-
Kevin E. Lofton
Lead Independent Director; Retired Chief Executive Officer, CommonSpirit Health
-
Ted W. Love, MD
Chair of Board of Directors, Biotechnology Innovation Organization
-
Harish Manwani
Retired Chief Operating Officer, Unilever
-
Javier J. Rodriguez
Chief Executive Officer, DaVita Inc.
-
Anthony Welters
Chairman and Chief Executive Officer, CINQ Care Inc.; Executive Chairman, BlackIvy Group, LLC; Chairman, Somatus Inc.